03



01.16.2011

Curriculum Vitae

Gang Hu, M.D., M.P.H., Ph.D., Assistant Professor

Office Address: Chronic Disease Epidemiology Laboratory

Pennington Biomedical Research Center

Louisiana State University System

6400 Perkins Road

Baton Rouge, Louisiana 70808

Tel: (225) 763-3053

Fax: (225) 763-3009

Email: gang.hu@pbrc.edu

Education:

2005 Adjunct professor (Docent), University of Helsinki, Finland (Field: Public Health)

2001 Ph.D. Faculty of Medicine, University of Kuopio, Finland (Field: Sport Medicine)

2000 M.P.H. Faculty of Medicine, University of Kuopio, Finland (Field: Public Health)

1989 M.D. Tianjin Medical University, P. R. China

POSTDOCTORAL TRAINING:

2003. Post-doctor fellow, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, and Department of Public Health, University of Helsinki, Finland

2003-2005 Senior academy postdoctoral researcher, Academy of Finland, Finland

PROFESSIONAL EXPERIENCE:

2010-present Adjunct assistant professor, Epidemiology Program, School of Public Health,

Louisiana State University Health Sciences Center (LSUHSC)

2010-present Adjunct assistant professor, the Graduate School, Louisiana State University

2010-present Adjunct assistant professor, School of Human Ecology, Louisiana State University

2009-present Assistant professor & Director, Chronic Disease Epidemiology Laboratory, Pennington Biomedical Research Center, Louisiana State University System

2007-present Guest professor, Tianjin Women’s and Children’s Health Center, Tianjin, China

2005-precent Adjunct professor (Docent) of Public Health, University of Helsinki, Finland

2008. Senior researcher, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, and Department of Public Health, University of Helsinki, Finland

2003-2005 Senior academy postdoctoral researcher, Academy of Finland, Finland

2003. Post-doctor research fellow, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, and Department of Public Health, University of Helsinki, Finland

2001. Researcher and postgraduate student for Ph.D., Departments of Physiology and Public Health and General Practice, University of Kuopio, Finland

1998. Senior researcher, Department of Nutrition, Food Safety Control and Inspection Institute, Tianjin, P. R. China

1989-1995 Researcher, Department of Nutrition, Food Safety Control and Inspection Institute, Tianjin, P. R. China

PROFESSIONAL ACTIVITIES:

Society Membership:

• American Diabetes Association (2009-)

• American Heart Association (2009-)

• American Stroke Association (2009-)

• European Association for the Study of Diabetes (European Diabetes Epidemiology Group) (2001-)

• European Association for Cardiovascular Prevention and Rehabilitation (2005-)

• European Society of Hypertension (2006-)

• Finnish Hypertension Society (2006-)

• The International Diabetes Federation (International Diabetes Epidemiology Group) (2003-)

Member of the Editorial Board for the Scientific Journals:

• Current Diabetes Reviews (2004-)

• Obesity Research, Guest Editor (2006)

• The Open General & Internal Medicine Reviews (OGMR) (2007-2010)

• The Open Hematology Journal (2007-)

• ClinicoEconomics & Outcomes Research (2008-)

• Nutrition and Metabolic Insights (2008-)

• The Open Diabetes Journal (2008-)

• The Open Hypertension Journal (2008-)

• World Journal of Diabetes (2009-)

• Journal of Geriatric Cardiology (2011-)

Regular Reviewer for the Following Scientific Journals:

• American Journal of Cardiovascular Drugs (2007)

• American Journal of Epidemiology (2004-2011)

• American Journal of Hypertension (2004-2007)

• Annals of Internal Medicine (2006)

• Annals of Nutrition and Metabolism (2007)

• Archive of Internal Medicine (2007)

• Atherosclerosis (2006, 2008, 2010)

• BMC Public Health (2006-2008)

• British Journal of Nutrition (2009, 2010)

• British Journal of Sports Medicine (2006, 2007)

• British Medical Journal (2010)

• Cancer Detection and Prevention (2007)

• Cardiovascular Diabetology (2009)

• Circulation (2005-2011)

• Clinica Chimica Acta (2004)

• Clinical Endocrinology (2006)

• Current Diabetes Reviews (2004-2010)

• Current Pharmaceutical Design (2007)

• Diabetes Care (2006-2011)

• Diabetic Medicine (2002, 2003, 2004, 2006)

• Diabetes Research and Clinical Practice (2004-2007, 2009)

• Diabetes & Metabolism (2006)

• Diabetologia (2005, 2007)

• European Heart Journal (2006-2009)

• European Journal of Cardiovascular Prevention and Rehabilitation (2006-2008)

• European Journal of Clinical Nutrition (2006)

• European Journal of Epidemiology (2006, 2008)

• European Journal of Internal Medicine (2008)

• European Journal of Neurology (2008)

• Gender Medicine (2005, 2008)

• Hepatology (2009)

• Hormone and Metabolic Research (2004)

• Hypertension (2006, 2007)

• International Diabetes Monitor (2003)

• International Journal of Behavioral Nutrition and Physical Activity (2004)

• International Journal of Medical Sciences (2006)

• International Journal of Obesity and Related Metabolic Disorders (2004)

• Journal of Diabetes and Its Complications (2002, 2008)

• Journal of Internal Medicine (2006)

• Journal of Physical Activity and Health (2007)

• Journal of the Neurological Sciences (2007, 2008)

• Journal of Women's Health (2007)

• Medicine and Science in Sports and Exercise (2002, 2007, 2008)

• Medical Science Monitor (2007)

• Metabolic Syndrome and Related Disorders (2007)

• Movement Disorders (2007, 2008)

• Neurology (2008, 2009)

• Nutrition, Metabolism & Cardiovascular Diseases (2009)

• Obesity (2004-2007)

• Obesity Review (2011)

• Open General & Internal Medicine Reviews (2007, 2009)

• PLoS ONE (2010)

• Preventing Chronic Disease (2008)

• Preventive Medicine (2005-2010)

• Public Health Nutrition (2005)

• Social Science & Medicine (2003, 2008)

• Sport Medicine (2007)

• Stroke (2005-2007)

• The American Journal of Cardiology (2007, 2008)

• The Journal of the American College of Nutrition (JACN) (2007)

• The Journal of the American Medical Association (JAMA) (2004, 2007, 2009)

• The Lancet (2008)

• The Open Diabetes Journal (2010)

• The Open Hematology Journal (2008)

• Vascular Health and Risk Management (2008)

Regular Reviewer for Grants:

• 2006 Diabetes Foundation – Diabetes UK Senior Research Fellowship

• 2008 The Chinese University of Hong Kong – Hong Kong Research Grants Council

Member of the Abstract Reviewing Committee for Scientific Congress:

• 2008 European Society of Cardiology (ESC) Congress

• 2009 European Society of Cardiology (ESC) Congress

Official Reviewer for PhD Student Thesis

• 2010 Tomi Makinen, University of Helsinki: Trends and Explanations for Socioeconomic

Differences in Physical Activity

Scientific Supervision (Post-Doc, PhD and Master):

Official Supervisor (Post-Doc):

• On-going Yurong Zhang, Pennington Biomedical Research Center

Official Supervisor (PhD):

• On-going Yujie Wang, Louisiana State University: Lifestyle factors and the risk of heart failure

• On-going Riikka Lehtisalo, University of Helsinki: Epidemiology of hypertension and type 2

diabetes in Finland

Official Supervisor (Master):

• On-going Wei Li, Department of Experimental Statistics, Louisiana State University

• On-going Yujie Wang, Louisiana State University: Lifestyle factors and the risk of heart failure

• 2011 Wenting Xie, Department of Experimental Statistics, Louisiana State University

Non-official Supervisor (PhD):

• 2008 Siamak Bidel, University of Helsinki: Coffee and risk of type 2 diabetes

• 2006 Noel Barengo, University of Kuopio: Physical activity, cardiovascular risk factors and

mortality

• 2005 Jianjun Wang, University of Helsinki: Assessment of the metabolic syndrome in predicting incident type 2 diabetes in a Chinese population

Invited Lecture at Universities, Institutes or Scientific Congress:

• 06/18/10 “Exercise, Body Weight and Cardiovascular Risk”, and The China Health

Communications Award Program (Balance between Diet & Exercises 2010) KOLs - Media Knowledge Sharing Meeting, Beijing, China

• 06/18/10 “Exercise, Obesity and Health”, National Institute of Sport Medicine, Beijing, China

• 06/17/10 “Cardiovascular disease and exercise”, The Chinese Society of Cardiology - China

CDC - Ministry of Health Joint Session “CVD Prevention and Control: from Research to Action”, World Congress of Cardiology Scientific Sessions 2010, Beijing, China, June 16-19, 2010

• 03/17/10 “Physical activity, obesity and metabolic health”, School of Public Health, Louisiana

State University Health Science Center

• 03/10/10 “Physical activity and the risk of metabolic disease”, Department of Kinesiology,

Louisiana State University (course KIN 7999)

• 04/29/09 “Joint effects of physical activity and body weigh on the risk of several chronic diseases”, School of Human Ecology, Louisiana State University

• 10/06 Coffee Roaster’s Association, Finland

• 2005-2008 University of Helsinki, Finland

• 2000 University of Kuopio, Finland

• 1995 Tianjin Medical University, P. R. China

Faculty or International Advisory Board at Scientific Congress:

• 07/2010 Scientific Advisory Board, 15th World Congress on Heart Disease, Annual Scientific

Sessions 2010, Vancouver, BC, Canada, July 24-27, 2010

• 06/2010 Faculty, World Congress of Cardiology Scientific Sessions 2010, Beijing, China, June

16-19, 2010

Organization at Scientific Congress:

• 06/2010 The Chinese Society of Cardiology - China CDC - Ministry of Health Joint Session

Chairs, “CVD Prevention and Control: from Research to Action”, World Congress of

Cardiology Scientific Sessions 2010, Featuring the 3rd International Conference on

Women, Heart Disease and Stroke, Beijing, China, June 16-19, 2010

International Training:

• 2005 WHO/Euro CINDI Programme: The CINDI Winter School, National Public Health

Institute, Helsinki, Finland

• 2005 Summer School of the European Society of Hypertension, Visegrad, Hungary

• 2003 The 8th Cambridge WHO/IDF Seminar on the Epidemiology and Public Health

Aspects of Diabetes, Cambridge, UK

• 1999 International Visitors’ Programme of the North Karelia Project in Finland,

National Public Health Institute, Helsinki, Finland

TEACHING EXPERIENCE/RESPONSIBILITIES:

In US

• 03/2010 Lecture on “Physical activity, obesity and metabolic health”, Epidemiology Seminar,

School of Public Health, Louisiana State University Health Science Center

• 03/2010 Lecture on “Physical activity and the risk of metabolic disease”, Department of

Kinesiology, Louisiana State University (course KIN 7999)

• 04/2009 Lecture on “Joint effects of physical activity and body weigh on the risk of several

chronic diseases”, Human Nutrition and Food Seminar School of Human Ecology,

Louisiana State University

In Finland

• 2005-2008 Lecture on “Health Status in China”, Cardiovascular Epidemiology (Course for PhD

students), University of Helsinki, Finland

Grant Support:

Ongoing

Project Huiguang Tian 07/01/2010-06/30/2013

International Diabetes Federation - Bringing Research in Diabetes to Global Environments and Systems (BRIDGES)

A randomized translational study to examine the effects of shared care versus usual care in management of gestational diabetes in a three-tier prenatal care network in Tianjin

Role: Senior Investigator

Project Jaakko Tuomilehto 10/01/2009-09/30/2011

Finnish Cancer Foundation

Prospective analysis of lifestyle factors and cancer risk in Finnish cohorts of middle-aged people

Role: Co-Principal Investigator

Project Gang Hu 09/01/2009-08/31/2010

Merck

Association of high-density lipoprotein cholesterol with the risk of incident coronary heart disease/cardiovascular disease by different levels of low-density lipoprotein cholesterol

Role: Principal Investigator

Project Huiguang Tian & Gang Hu 03/01/2009-12/31/2012

European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly Programme for Collaborative Research between China and Europe

A study of the interaction in lifestyle and genetic factors on the incidence of type 2 diabetes in Chinese women with gestational diabetes after delivery

Role: Co-Principal Investigator

Completed

Project Jaakko Tuomilehto 01/01/2010-12/31/2010

Juho Vainio Foundation, Finland

Prospective analysis of lifestyle factors and cancer risk in Finnish cohorts of middle-aged people

Role: Co-Principal Investigator

Project Pekka Jousilahti 01/01/2007-12/31/2010

Academy of Finland

Dietary, Lifestyle, and Genetic Determinants of Obesity and Metabolic Syndrome (DILGOM)

Role: Senior Investigator

Project Jaakko Tuomilehto 01/01/2009-12/31/2009

Juho Vainio Foundation, Finland

Prospective analysis of lifestyle factors and cancer risk in Finnish cohorts of middle-aged people

Role: Co-Principal Investigator

Project Jaakko Tuomilehto 10/01/2008-09/30/2009

Finnish Cancer Foundation

Prospective analysis of lifestyle factors and cancer risk in Finnish cohorts of middle-aged people

Role: Co-Principal Investigator

Project Noel Barengo 05/01/2008-12/31/2009

Finnish Heart Association

Trends of glucose metabolism disorders, treatment of hypertension and its effects over time regarding cardiovascular disease, stroke and all-cause mortality

Role: Co-Principal Investigator

Project Gang Hu 05/01/2006-12/31/2008

Finnish Heart Association

The role of physical activity in cardiovascular disease prevention

Role: Principal Investigator

Project Gang Hu 05/01/2005-12/31/2007

Finnish Heart Association

Diabetes, myocardial infraction, hypertension and other cardiovascular risk factors on the risk of coronary mortality and stroke incidence and stroke mortality

Role: Principal Investigator

Project Jaakko Tuomilehto 05/01/2005-12/31/2006

The Finnish Parkinson Foundation

Lifestyle factors and the risk of Parkinson’s disease

Role: Co-Principal Investigator

Project Jaakko Tuomilehto 01/01/2005-12/31/2006

Juho Vainio Foundation, Finland

Coffee drinking and the risk of type 2 diabetes

Role: Co-Principal Investigator

Project Jaakko Tuomilehto 10/01/2004-09/30/2006

AstraZeneca R&D Mölndal, Sweden

Diabetes, impaired glucose tolerance, dyslipidemia and mortality in European population

Role: Co-Principal Investigator

Project 204274 Gang Hu 01/08/2003-12/31/2005

Academy of Finland

Epidemiology of the metabolic syndrome in Finland and Europe

Role: Principal Investigator

Project 205657 Gang Hu 01/08/2003-12/31/2005

Academy of Finland

Epidemiology of the metabolic syndrome in Finland and Europe

Role: Principal Investigator

Project Jaakko Tuomilehto 01/01/2003-12/31/2004

AstraZeneca R&D Mölndal, Sweden

The prevalence of the metabolic syndrome in the general population and its relation to morbidity and mortality

Role: Co-Principal Investigator

Project 53585 Pekka Jousilahti 01/01/2001-31/12/2003

Academy of Finland

The health consequences of obesity in Finland

Role: Senior Investigator

Awards or Honors:

• 2011 The Mark Bieber Award. American Heart Association

• 2009 Article (Hepatology 2008;48:129-136) was selected for Faculty of 1000 Medicine.

• 2009 Article (International Journal of Obesity 2008;32:975-984) was listed the top 1 most

downloaded highlights from the international website of Nature China of 2008.

• 2007 Marquis Who’s Who in the World, 25th edition

• 2005 The Ralph S. Paffenbarger Jr. Poster Award (the second Finalist). International XVIII

Puijo Symposium, Kuopio, Finland

• 2001 Honorary Member of the Order of the Horse Collar Knights, University of Kuopio,

Finland

• 1984-1989 Scholarship Award for Outstanding Students, Tianjin Medical University, China

PUBLICATIONS

Peer-reviewed Journal Articles (impact factors)

1. Hu G, Cui Y, Jousilahti P, Sundvall J, Girman CJ, Antikainen R, Laatikainen T, Tuomilehto J. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease. European Heart Journal, revised manuscript. (9.800)

2. Qiu C, Hu G, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L, Jousilahti P, Tuomilehto J. Hypertension and the risk of Parkinson’s disease: National FINRISK Study. Hypertension, revised manuscript. (6.614)

3. Wang Y, Tuomilehto J, Jousilahti P, Salomaa V, Antikainen R, Mähönen M, Katzmarzyk PT, Hu G. High Level of Serum Gamma-glutamyltransferase Predicts Incident Heart Failure in Finnish Men and Women. Journal of the American College of Cardiology, revised manuscript (12.535).

4. Zhang Z, Hu G, Caballero B, Appel L, Chen L. Habitual Coffee Consumption and Risk of Hypertension: A Meta-Analysis of Prospective Studies. American Journal of Clinical Nutrition, revised manuscript. (6.307)

5. Hu G. Bouchard C, Bray GA, Greenway FL, Johnson WD, Newton Jr RL, Ravussin E, Ryan D, Katzmarzyk PT. Trunk versus extremity fat and cardiometabolic risk factors in white and African American adults. Diabetes Care, revised manuscript. (6.718).

6. Bowers K, Liu G, Wang P, Ye T, Tian Z, Liu E, Yu Z, Yang X, Klebanoff M, Yeung E, Hu G, Zhang C. Birth weight, postnatal weight change, and risk for high blood pressure among Chinese children aged 3-6 years. Pediatrics, in press. (4.687)

7. Shi Z, Yuan BJ, Hu G, Dai Y, Zuo H, Holmboe-Ottesen G. Dietary pattern and weight change in a 5 year follow up among Chinese adults: Results from Jiangsu Nutrition and Health Study. British Journal of Nutrition, in press. (3.446)

8. Zhang FX, Dong L, Zhang CP, Li BJ, Wen J, Gao W, Sun SR, Lv FJ, Tian HG, Tuomilehto J, Qi L, Zhang CL, Yu ZJ, Yang XL, Hu G. Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabetic Medicine, in press. (2.871)

9. Wang Y, Tuomilehto J, Jousilahti P, Antikainen R, Mähönen M, Katzmarzyk PT, Hu G. Coffee consumption and the risk of heart failure. Heart 2011; 97: 44-48. (5.385)

10. Bidel S, Hu G, Jousilahti P, Antikainen R, Pukkala E, Hakulinen T, Tuomilehto J. Coffee Consumption and Risk of Colorectal Cancer. European Journal of Clinical Nutrition 2010; 64: 917-923. (3.072)

11. Hu G. Total cholesterol and the risk of Parkinson’s disease: a review for some new findings. Parkinson's Disease Volume 2010, Article ID 836962, 6 pages.

12. Hu G, Jousilahti P, Antikainen R, Katzmarzyk PT, Tuomilehto J. Joint effects of physical activity, body mass index, waist circumference and waist-hip ratio with the risk of heart failure. Circulation 2010; 121: 237-244. (14.816)

13. Shi Z, Hu X, Yuan B, Hu G, Pan X, Dai Y, Holmboe-Ottesen G, Byles J. Association between food pattern and metabolic syndrome in China. Journal of Diabetology 2010; 2: 3 (1-12).

14. Tian Z, Ye T, Zhang XY, Liu EQ, Wang W, Wang P, Liu GS, Yang XL, Hu G, Yu ZJ. Sleep duration and hyperglycaemia among obese and non-obese children aged 3 to 6 years. Archives of Pediatrics & Adolescent Medicine 2010; 164: 46-52. (4.726).

15. Wang Y, Hu G. The individual and joint associations of obesity and physical activity on the risk of heart failure. Congestive Heart Failure 2010; 16: 292-299.

16. Wang Y, Tuomilehto J, Jousilahti P, Antikainen R, Mähönen M, Katzmarzyk PT, Hu G. Occupational, commuting and leisure-time physical activity in relation to heart failure among Finnish men and women. Journal of the American College of Cardiology 2010; 56: 1140-1148. (12.535).

17. Barengo NC, Hu G, Kastarinen M, Antikainen R, Tuomilehto J. The effects of awareness, treatment and control of hypertension on future stroke incidence in a community-based population study in Finland. Journal of Hypertension 2009; 27: 1459-1465. (4.988)

18. Du X, Zhu BL, Hu G, Mao WG, Wang SQ, Zhang H, Wang F, Shi ZM. U-shape association between white blood cell count and the risk of diabetes in young Chinese adults. Diabetic Medicine 2009; 26: 955-960. (2.871)

19. Hu G. Vascular risk factors and the risk of Parkinson’s disease: some new findings. North American Journal of Medicine and Science 2009; 2: 29-33.

20. Hu G, Jousilahti, P, Tuomilehto J, Antikainen R, Sundvall J Salomaa V. Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective Finnish study. The Journal of Clinical Endocrinology & Metabolism 2009; 94: 2099-2105. (6.202)

21. Khalangot M, Hu G, Tronko M, Kravchenko V, Guryanov V. Gender risk of non-fatal stroke in type 2 diabetic patients differs depending on the type of treatment. Journal of Women Health 2009; 18: 97-103 (1.770).

22. Khalangot M, Tronko M, Kravchenko V, Culchinska J, Hu G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine. Heart 2009; 95: 454-460. (5.385)

23. Tian HG, Song GD, Xie HX, Zhang H, Tuomilehto J, Hu G. Prevalence of diabetes and impaired fasting glucose among 767,160 rural Chinese adults. Diabetes Research and Clinical Practice 2009: 84: 273-278. (2.160)

24. Tian HG, Xie HX, Song GD, Zhang H, Hu G. Prevalence of overweight and obesity among 2.6 million rural Chinese adults. Preventive Medicine 2009; 48: 59-63. (3.172)

25. Zhang XY, Liu EQ, Tian Z, Wang W, Ye T, Liu GS, Li YM, Wang P, Yang XL, Yu ZJ, Hu G. High birth weight and overweight or obesity among Chinese children 3-6 years old. Preventive Medicine 2009; 49:172-178. (3.172)

26. Bidel S, Hu G, Tuomilehto J. Coffee consumption and type 2 diabetes – an extensive review. Central European Journal of Medicine 2008; 3: 9-19. (0.224)

27. Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J. Coffee consumption, serum gamma-glutamyltransferase and risk of type 2 diabetes. European Journal of Clinical Nutrition 2008; 62: 178-185. (3.072)

28. Hu G, Antikainen R, Jousilathi P, Kivipelto M, Tuomilehto J. Total cholesterol and the risk of Parkinson disease. Neurology 2008; 70: 1972-1979. (8.172).

29. Hu G, Lindström J, Jousilahti P, Peltonen M, Sjöberg L, Kaaja R, Sundvall J, Tuomilehto J. The increasing prevalence of metabolic syndrome among Finnish men and women over a decade. The Journal of Clinical Endocrinology & Metabolism 2008; 93: 832-836. (6.202)

30. Hu G, Tuomilehto J, Pukkala E, Hakulinen T, Antikainen R, Vartiainen E, Jousilahti P. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology 2008; 48: 129-136. (10.840)

31. Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes. Diabetes Research and Clinical Practice 2008; 82: 139-147. (2.160)

32. Qi L, Hu, FB, Hu G. Genetic, exercise and prevention of type 2 diabetes. Current Molecular Medicine 2008; 8: 519-532. (5.096)

33. Shi ZM, Hu XS, Yuan BJ, Hu G, Pan XQ, Byles JE, Holmboe-Ottesen G. Vegetable-rich food pattern is related to obesity in China. International Journal of Obesity 2008; 32: 975-984. (4.343)

34. Shi ZM, Hu XS, Yuan BJ, Hu G, Pan XQ, Holmboe-Ottesen G. Coexistence of anaemia and the metabolic syndrome in adults in Jiangsu, China. Asia Pacific Journal of Clinical Nutrition 2008; 17: 505-513. (1.214)

35. Barengo NC, Hu G, Tuomilehto J. Physical activity and hypertension: evidence of cross-sectional studies, cohort studies and meta-analysis. Current Hypertension Reviews 2007; 3: 255-263.

36. Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J. Coffee and tea consumption and the risk of Parkinson’s disease. Movement Disorders 2007; 22: 2242-2248. (4.014)

37. Hu G, Jousilahti P, Antikainen R, Tuomilehto J. Occupational, commuting, and leisure-time physical activity in relation to cardiovascular mortality among Finnish subjects with high blood pressure. American Journal of Hypertension 2007; 20: 1242-1250. (3.036)

38. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Type 2 diabetes and the risk of Parkinson’s disease. Diabetes Care 2007; 30: 842-847. (6.718)

39. Hu G, Jousilahti P, Borodulin K, Barengo NC, Lakka TA, Nissinen A, Tuomilehto J. Occupational, commuting, and leisure-time physical activity in relation to coronary heart disease among middle-aged Finnish men and women. Atherosclerosis 2007; 194: 490-497. (4.522)

40. Hu G, Jousilahti P, Nissinen A, Bidel S, Antikainen R, Tuomilehto J. Coffee consumption and the incidence of antihypertensive drug treatment in Finnish men and women. American Journal of Clinical Nutrition 2007; 86: 457-464. (6.307)

41. Hu G, Jousilathi P, Tuomilehto J. Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease. European Heart Journal 2007; 28: 3059-3066. (9.800)

42. Hu G, Lakka TA, Kilpelainen TO, Tuomilehto J. Epidemiological studies of exercise in diabetes prevention. Applied Physiology, Nutrition, and Metabolism 2007; 32; 583-595. (1.968)

43. Hu G, Tuomilehto J, Borodulin K, Jousilahti P. The joint associations of occupational, commuting, and leisure-time physical activity, and the Framingham risk score on the 10-year risk of coronary heart disease. European Heart Journal 2007; 28: 492-498. (9.800)

44. Hu G, Tuomilehto J, Silventoinen K, Sarti C, Männistö S, Jousilahti P. Body mass index, waist circumference and waist-hip ratio on the risk of total and type-specific stroke. Archive of Internal Medicine 2007; 167: 1420-1427. (9.813)

45. Wang JJ, Li HB, Kinnunen L, Hu G, Järvinen TM, Miettinen ME, Yuan SY, Tuomilehto J. How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population? Atherosclerosis 2007; 192: 161-168. (4.522)

46. Bidel S, Hu G, Sundvall J, Kaprio J, Tuomilehto J. Effects of coffee consumption on glucose tolerance, serum glucose and insulin levels – a cross-sectional analysis. Hormone and Metabolic Research 2006; 38: 38-43. (2.686)

47. Bidel S*, Hu G*, Qiao Q, Jousilahti P, Antikainen R, Tuomilehto J. Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia 2006; 49: 2618-2626. (6.551) (*Co-first author)

48. Hu G, Jousilahti P, Nissinen A, Antikainen R, Kivipelto M, Tuomilehto J. Body mass index and the risk of Parkinson’s disease. Neurology 2006; 67: 1955-1959. (8.172)

49. Hu G, Jousilahti P, Peltonen M, Bidel S, Tuomilehto J. Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland. International Journal of Obesity 2006; 30: 1742-1749. (4.343)

50. Hu G, Jousilahti P, Sarti C, Antikainen R, Tuomilehto J. The effect of diabetes and stroke at baseline and during follow-up on stroke mortality. Diabetologia 2006; 49: 2309-2316. (6.551)

51. Hu G, Lakka TA, Lakka HM, Tuomilehto J. Lifestyle management in the Metabolic Syndrome. Metabolic Syndrome and Related Disorders 2006; 4: 270-286.

52. Hu G, Rico-Sanz J, Lakka TA, Tuomilehto J. Exercise, genetics and prevention of type 2 diabetes. Essays in Biochemistry 2006; 42: 177-192. (2.816)

53. Lee DH, Silventoinen K, Hu G, Jacobs Jr DR, Jousilahti P, Tuomilehto J. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28838 middle-aged men and women. European Heart Journal 2006; 27: 2170-2176. (>50 citations) (9.800)

54. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K for the DECODA Study Group. Screen-detected diabetes, hypertension and hypercholesteremia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. European Journal of Cardiovascular Prevention and Rehabilitation 2006; 13: 555-561. (2.511)

55. Barengo NC, Hu G, Kastarinen M, Lakka TA, Pekkarinen H, Nissinen A, Tuomilehto J. Low physical activity as a predictor for antihypertension drug treatment in 25-64-years-old populations in Eastern and South-West Finland. Journal of Hypertension 2005; 23: 293-299. (4.988)

56. Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J. Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care 2005; 28: 799-805. (6.718)

57. Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 2005; 48: 856-861. (6.551)

58. Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. Journal of the American College of Cardiology 2005; 45: 1413-1418. (12.535)

59. Hu G, Jousilahti P, Peltonen M, Lindström J, Tuomilehto J. Urinary sodium and potassium excretion and the risk of type 2 diabetes: a prospective study in Finland. Diabetologia 2005; 48: 1477-1483. (6.551)

60. Hu G, Lakka TA, Barengo NC, Tuomilehto J. Physical activity, physical fitness and the risk of type 2 diabetes. Metabolic Syndrome and Related Disorders 2005; 3: 35-44.

61. Hu G, Qiao Q, Tuomilehto J. The metabolic syndrome and cardiovascular risk. Current Diabetes Reviews 2005; 1: 137-144.

62. Hu G, Sarti C, Jousilahti P, Peltonen M, Qiao Q, Antikainen R, Tuomilehto J. The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 2005; 36: 2538-2543. (7.041).

63. Hu G, Sarti C, Jousilahti P, Silventoinen K, Barengo NC, Tuomilehto J. Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke 2005; 36: 1994-1999. (>60 citations) (7.041)

64. Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Peltonen M, Jousilahti P. The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47212 middle-aged Finnish men and women. International Journal of Obesity 2005; 29: 894-902. (>70 citations) (4.343)

65. Patja K, Jousilahti P, Hu G, Valle TT, Qiao Q, Tuomilehto J. Effects of smoking, obesity and physical activity on the risk of type 2 diabetes in middle-aged Finnish men and women. Journal of Internal Medicine 2005; 258: 356-362. (5.942)

66. Qiao Q, Pyörälä K, Tuomilehto J, Gao WG, Hu G, Peltonen M, Dekker JM, Alberti KGMM for the DECODE Study Group. Comparison of three different definitions for the metabolic syndrome in non-diabetic Europeans. The British Journal of Diabetes & Vascular Disease 2005; 5: 161-168.

67. Silventoinen K, Pankow J, Jousilahti P, Hu G, Tuomilehto J. Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. International Journal of Epidemiology 2005; 34: 327-334. (5.262)

68. Silventoinen K, Pankow J, Lindström J, Jousilahti P, Hu G, Tuomilehto J. The validity of the Finnish Diabetes Risk Score for prediction of the incidence of coronary heart disease and stroke, and total mortality. European Journal of Cardiovascular Prevention and Rehabilitation 2005; 12: 451-458. (2.511)

69. Wang JJ, Hu G, Lappalainen J, Miettinen ME, Qiao Q, Tuomilehto J. Changes in features of the metabolic syndrome and incident impaired glucose regulation or type 2 diabetes in a Chinese population. Diabetes Care 2005; 28: 448-450. (6.718)

70. Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyörälä K for the DECODE Study Group. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia 2004; 47: 2118-2128. (6.551)

71. Barengo NC, Hu G, Lakka TA, Pekkarinen H, Nissinen A, Tuomilehto J. Low physical activity as a predictor for total and cardiovascular disease mortality in middle-aged men and women in Finland. European Heart Journal 2004; 25: 2204-2211. (>70 citations) (9.800)

72. Hu G, Barengo NC, Tuomilehto J, Lakka TA, Nissinen A, Jousilahti P. Relationship of physical activity and body mass index to the risk of hypertension: a prospective study in Finland. Hypertension 2004; 43: 25-30. (>70 citations) (6.614)

73. Hu G, Eriksson JG, Barengo NC, Lakka TA, Valle TT, Nissinen A, Jousilahti P, Tuomilehto J. Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes. Circulation 2004; 110: 666-673. (>60 citations) (14.816)

74. Hu G, Lakka TA, Barengo NC, Tuomilehto J. Physical activity in the prevention of type 2 diabetes. Cardiovascular Medicine (Office Journal of the Swiss Society of Angiology, the Swiss Society of Endocrinology & Diabetology as well as the Swiss Hypertension Society) 2004; 7: 394-405.

75. Hu G, Lindström J, Valle TT, Eriksson JG, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal and impaired glucose regulation. Archive of Internal Medicine 2004; 164: 892-896. (>100 citations) (9.813)

76. Hu G, Qiao Q, Tuomilehto J. The metabolic syndrome and cardiovascular risk: is it different between men and women. XX vs. XY 2004; 2: 15-20.

77. Hu G, Qiao Q, Tuomilehto J. Balkau B, Borch-Johnsen K, Pyörälä K for the DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Archive of Internal Medicine 2004; 164: 1066-1076. (>350 citations) (9.813)

78. Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens E, Pyörälä K for the DECODE Study Group. Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 2004; 47: 1245-1256. (6.551)

79. Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Jousilahti P. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. European Heart Journal 2004; 25: 2212-2219. (>80 citations) (9.800)

80. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K for the DECODA Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 2004; 47: 385-394. (>60 citations) (6.551)

81. Sarlio-Lähteenkorva S, Silventoinen K, Jousilahti P, Hu G, Tuomilehto J. The association between thinness and socio-economic disadvantage, health indicators, and adverse health behaviour: a study of 28000 Finnish men and women. International Journal of Obesity and Related Metabolic Disorders 2004; 28: 568-573. (4.343)

82. Tuomilehto J, Hu G, Bidel S, Lindström J, Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. The Journal of the American Medical Association (JAMA) 2004; 291: 1213-1219. (>110 citations) (28.899)

83. Wang JJ, Hu G, Miettinen ME, Tuomilehto J. The metabolic syndrome and incident diabetes: Assessment of four suggested definitions of the metabolic syndrome in a Chinese population with high post-prandial glucose. Hormone and Metabolic Research 2004; 36: 708-715. (2.686)

84. Wang JJ, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care 2004; 47: 2429-2437. (6.718)

85. Wang JJ, Yuan SY, Zhu LX, Fu HJ, Li HB, Hu G, Tuomilehto J. Effects of impaired fasting glucose and impaired glucose tolerance on predicting incident type 2 diabetes in a Chinese population with high post-prandial glucose. Diabetes Research and Clinical Practice 2004; 66: 183-191. (2.160)

86. Hu G, Qiao Q, Silventoinen K, Eriksson JG, Jousilahti P, Lindström J, Valle TT, Nissinen A, Tuomilehto J. Occupational, commuting, leisure-time physical activity in relation to risk for type 2 diabetes in middle-aged Finnish men and women. Diabetologia 2003; 46: 322-329. (>100 citations) (6.551)

87. Hu G, Qiao Q, Tuomilehto J. Balkau B, Borch-Johnsen K for the DECODE Study Group. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 2003; 46: 608-617. (>60 citations) (6.551)

88. Hu G, Tuomilehto J. Coffee, tea and their impact on the risk of diabetes. International Diabetes Monitor 2003; 15 (6): 1-5.

89. Nakagami T, Qiao Q, Carstensen B, Nøhr-Hansen C, Hu G, Tuomilehto J, Balkau B, Borch-Johnsen K for the DECODE-DECODA Study Group. Age, body mass index and type 2 diabetes – associations modified by ethnicity. Diabetologia 2003; 46: 1063-1070. (6.551)

90. Qiao Q, Hu G, Tuomilehto J. Eriksson JG, Balkau B, Borch-Johnsen K for the DECODE Study Group. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003; 26: 61-69. (>130 citations) (6.718)

91. Qiao Q, Hu G, Tuomilehto J, Nakagami T, Balkau B, Borch-Johnsen K, Ramachandran A, Mohan V, Iyer SR, Tominaga M, Kiyohara Y, Kato I, Okubo K, Nagai M, Shibazaki S, Yang Z, Tong Z, Fan Q, Wang B, Chew SK, Tan BY, Heng D, Emmanuel S, Tajima N, Iwamoto Y, Snehalatha C, Vijay V, Kapur A, Dong Y, Nan H, Gao W, Shi H, Fu F for the DECODA Study Group. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003; 26: 1770-1780. (>70 citations) (6.718)

92. Tuomilehto J, Hu G. Physical fitness and risk factors for cardiovascular disease and type 2 diabetes. International Diabetes Monitor 2003; 15 (2): 5-7.

93. Hu G, Pekkarinen H, Hänninen O, Tian HG, Jin RP. Comparison of dietary and non-dietary risk factors in overweight and normal-weight Chinese adults. British Journal of Nutrition 2002; 88: 91-97. (3.446)

94. Hu G, Pekkarinen H, Hänninen O, Yu ZJ, Guo ZY, Tian HG. Commuting, leisure-time physical activity, and cardiovascular risk factors in China. Medicine and Science in Sports and Exercise 2002; 34: 234-238. (3.707)

95. Hu G, Pekkarinen H, Hänninen O, Yu ZJ, Tian HG, Guo ZY, Nissinen A. Physical activity during leisure and commuting in Tianjin, China. Bulletin of the World Health Organization 2002; 80: 933-938. (5.302)

96. Hu G, Qiao Q, Tuomilehto J. Non-hypertensive cardiac effects of a high salt diet. Current Hypertension Reports 2002; 4: 13-17. (2.377)

97. Yu ZJ, Nissinen A, Vartiainen E, Hu G, Tian HG, Guo ZY. Socioeconomic status and serum lipids: A cross-sectional study in a Chinese urban population. Journal of Clinical Epidemiology 2002; 55: 143-149. (2.956)

98. Hu G, Pekkarinen H, Halonen P, Hänninen O, Tian HG, Guo ZY, Kumpusalo E. Different worlds, different tasks for health promotion: comparisons of health risk profiles in Chinese and Finnish rural people. Health Promotion International 2001; 16: 315-320. (1.544)

99. Hu G, Pekkarinen H, Hänninen O, Tian HG, Guo ZY. Relation between commuting, leisure time physical activity and serum lipids in a Chinese urban population. Annals of Human Biology 2001; 28: 412-421. (1.064)

100. Hu G, Qiao Q, Tuomilehto J. Glucose tolerance and cardiovascular mortality. Cardiovascular Reviews & Reports 2001; 22: 649-654&692.

101. Hu G, Tian HG. A comparison of dietary and non-dietary factors of hypertension and normal blood pressure in a Chinese population. Journal of Human Hypertension 2001; 15: 487-493. (2.289)

102. Yang XL, Hsu-Hage BH-H, Tian HG, Hu G, Dong QN, Wu JH, Wahlqvist ML. The role of income and education in food consumption and nutrient intake in a Chinese population. Asia Pacific Journal of Clinical Nutrition 1998; 7: 217-223. (1.214)

103. Tian HG, Hu G, Nan Y, Shao RC, Gong QN. Relationship between serum lipids and dietary and non-dietary factors in a Chinese population. Chinese Journal of Prevention and Control Non-communicable Diseases 1997; 6: 304-310 (in Chinese).

104. Tian HG, Hu G, Dong QN, Yang XL, Nan Y, Pietinen P, Nissinen A. Dietary sodium and potassium, socioeconomic status and blood pressure in a Chinese population. Appetite 1996; 26: 235-246. (2.582)

105. Tian HG, Nan Y, Hu G, Dong QN, Yang XL. A dietary survey of the Chinese population in urban and rural areas of Tianjin. Asia Pacific Journal of Clinical Nutrition 1996; 5: 229-232. (1.214)

106. Tian HG, Hu G, Nan Y, Shao RC, Gong QN. Association between blood pressure and dietary intake and urinary excretion of sodium, potassium, calcium and magnesium in Tianjin. Chinese Journal of Prevention and Control Non-communicable Diseases 1996; 4: 203-208 (in Chinese).

107. Wang X, Yang XL, Hu G, Dong QN, Nan Y, Tian HG. Assessment of dietary consumption in Tianjin in 1992. Chinese Journal of Prevention and Control Non-communicable Diseases 1996; 1: 18-21 (in Chinese).

108. Hu G, Yu ZJ, Tian HG. Effect of nutrition intervention of low sodium salt intake in the NCD intervention area. Chinese Journal of Prevention and Control Non-communicable Diseases 1995; 3: 131-133 (in Chinese).

109. Nan Y, Tian HG, Shao RC, Hu G, Dong QN, Pietinen P, Nissinen A. Assessment of sodium and potassium in processed foods in an urban area in China. European Journal of Clinical Nutrition 1995; 49: 299-306. (3.072)

110. Tian HG, Guo ZY, Hu G, Yu ZJ, Sun W, Pietinen P, Nissinen A. Change in sodium intake and blood pressure in a community-based intervention project in China. Journal of Human Hypertension 1995; 9: 959-968. (2.289)

111. Tian HG, Nan Y, Hu G, Dong QN, Yang XL, Pietinen P, Nissinen A. Dietary survey in a Chinese population. European Journal of Clinical Nutrition 1995; 49: 26-32. (3.072)

112. Tian HG, Nan Y, Hu G, Shao RC, Gong QN. Assessment of sodium and potassium in children dietary in child-care center. Chinese Journal of Prevention and Control Non-communicable Diseases 1995; 6: 270-275 (in Chinese).

113. Tian HG, Nan Y, Shao RC, Gong QN, Hu G, Pietinen P, Nissinen A. Associations between blood pressure and dietary intake and urinary excretion of electrolytes in a Chinese population. Journal of Hypertension 1995; 13: 49-56. (4.988)

114. Yu ZJ, Nan Y, Hu G, Yang XL, Dong QN, Shao RC, Bao J, Wu JH, Jia M. Difference in salt intake of inhabitants in treatment and control communities of the Tianjin NCD Project. Chinese Journal of Prevention and Control Non-communicable Diseases 1995; 4: 166-168 (in Chinese).

115. Tian HG, Sun W, Yu ZJ, Hu G. Evaluation of dietary pattern in inhabitants of Tianjin. Chinese Journal of Prevention and Control Non-communicable Diseases 1993; 2: 22-25 (in Chinese).

Letters in Peer-reviewed Journals (impact factors)

116. Hu G, Antikainen R, Jousilathi P, Kivipelto M, Tuomilehto J. Total cholesterol and the risk of Parkinson’s disease-reply. Neurology 2009; 72: 860-861. (8.172).

117. Hu G, Tuomilehto J, Silventoinen K, Jousilahti P. Waist to hip ratio as a supplement to body mass index- reply. Archive of Internal Medicine 2008; 168: 238-238. (9.813)

118. Hu G, Jousilahti P, Tuomilehto J. Body mass index and the risk of Parkinson disease-reply. Neurology 2007; 68: 2156-2157. (8.174)

119. Hu G, Jousilahti P, Tuomilehto J. Prevalence of nonalcoholic Fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients: response to Talim. Diabetes Care 2007; 30: e56-e56. (6.718)

120. Hu G, Jousilahti P, Tuomilehto J. Obstructive sleep apnea as an independent risk factor for stroke and mortality-Reply. Stroke 2006; 37:1150. (7.041)

121. Patja K, Jousilahti P, Hu G, Valle TT, Qiao Q, Tuomilehto J. Tobacco smoke, systemic inflammation and the risk of type 2 diabetes-Reply. Journal of Internal Medicine 2006; 259: 333. (5.942)

Book-chapters

122. Hu G. Diabetes mellitus, Prevention. In: Mooren FC and Skinner JS ed. Encyclopedia of Exercise Medicine in Health and Disease. Springer 2011, in press.

123. Hu G, Tuomilehto J. Metabolic Syndrome. In: Mooren FC and Skinner JS ed. Encyclopedia of Exercise Medicine in Health and Disease. Springer 2011, in press.

124. Yu Z, Hu G, Yang X. The Prevalence of Overweight and Obesity and Related Metabolic Abnormalities among Children and Adolescents in China (Chapter 3). In: Segel CM. Children Obesity: Risk Factors, Health Effects and Prevention. Nova Science Publishers 2011, in press.

125. Zhang Y, Chen L, Hu G. Physical activity and hypertension: results from cohort studies and meta-analysis. In: . Physical Activity Education. Nova Science Publishers 2011, in press.

126. Hu G. The gender-specific impact of diabetes on the risk of cardiovascular disease (Chapter 5). In: Swahn EI. Diabetes in Women. Nova Science Publishers 2010: 83-100.

127. Hu G. Diabetes and women’s stroke risk (chapter 17). In: Berhardt LV ed. Advances in Medicine and Biology. Volume 1. Nova Science Publishers 2010: 393-404.

128. Hu G, Tuomilehto J. Diet and exercise in the prevention and treatment of diabetes and coronary heart disease (Chapter 3). In: Toth PP ed. The Year in Lipid Disorders, Volume 2. Atlas Medical Publishing Ltd 2010: 46-59.

129. Hu G. Diabetes and the risk of coronary disease among women (Chapter 4). In: Lardner BV and Pennelton HR ed. Heart Disease in Women. Nova Science Publishers 2009: 75-85.

130. Hu G, Lakka TA, Barengo NC, Tuomilehto J. Exercise and type 2 diabetes prevention (Chapter 5). In: Lignalli AT ed. Handbook of Type II Diabetes in the Middle Aged and Elderly. Nova Science Publishers 2009: 93-111.

131. Hu G, Lakka TA, Tuomilehto J. Physical activity, fitness and prevention of type 2 diabetes (Chapter 11). In: Lee IM ed. Epidemiologic Methods in Physical Activity Studies. Oxford University Press 2009: 201-224.

132. Hu G. Exercise and women’s health: results from FIN-MONICA study (Chapter 10). In: Allerton LT, Rutherfode GP ed. Exercise and Women’s Health: New Research. Nova Science Publishers 2008: 213-230.

133. Hu G, Lakka TA, Lakka HM, Tuomilehto J. Overweight, physical inactivity, insulin resistance, impaired glucose tolerance, diabetes, the metabolic syndrome and cardiovascular risk (Chapter 6). In: Craham IM, D’agostino RB ed. Therapeutic Strategies in Cardiovascular Risk. Atlas Medical Publishing Ltd 2008: 77-100.

134. Yu ZJ, Hu G. Prevalence of the metabolic syndrome and its relation to risks for cardiovascular disease (Chapter 3). In: Batone TE ed. Metabolic Syndrome Research Trends. Nova Science Publishers 2008: 89-103.

135. Hu G, Lakka TA, Lakka HM, Tuomilehto J. Obesity, physical activity, and nutrition in the metabolic syndrome (Chapter 9). In: Krentz AJ, Wong ND ed. Metabolic Syndrome and Cardiovascular Disease. Epidemiology, Assessment, and Management. Informa Healthcare, New York 2007: 241-277.

136. Hu G, Tuomilehto J. Lifestyle and outcome among patients with type 2 diabetes. In: Crepaldi G, Tiengo A, Avogaro A ed. The metabolic syndrome: the road map from inflammation to cardiovascular disease. International Congress Series 2007; 1303: 160-171.

137. Hu G, Tuomilehto J. Diet and exercise in the prevention and treatment of diabetes and coronary heart disease (Chapter 3). In: Packard CJ ed. The Year in Lipid Disorders, Volume 1. Atlas Medical Publishing Ltd 2007: 47-66.

138. Hu G, Yu ZJ. Physical activity and cardiovascular risk factors in China (Chapter 8). In: Saylor CP ed. Weight Loss, Exercise and Health Research. Nova Science Publishers 2006; 179-194.

139. Hu G. The SuRF Report 2 (China). In: World Health Organization ed. Surveillance of Chronic Disease Risk Factors: Country-level Data and Comparable Estimates. World Health Organization 2005.

140. Hu G, Qiao Q, Tuomilehto J. Metabolic syndrome, diabetes and coronary heart disease (Chapter 21). In: Marmot M, Elliott P ed. Coronary Heart Disease Epidemiology, Second Edition. Oxford University Press 2005: 311-330.

141. Tuomilehto J, Hu G, Qiao Q. Management of cardiovascular risk factors in patients with metabolic syndrome and type 2 diabetes (Chapter 5). In: Rosano G ed. Diabetes and Cardiovascular Disease. Wolters Kluwer 2005: 39-47.

142. Bidel S, Hu G, Tuomilehto J. Coffee and risk of type 2 diabetes. Proceedings of The Association Scientifique Internationale pour le Café (ASIC) Conferences: 20th International Scientific Colloquium on Coffee. Bangalore India, 2004.

143. Hu G. The SuRF Report 1 (China). In: World Health Organization ed. Surveillance of Risk Factors Related to Non-communicable Diseases: Current Status of Global Data. World Health Organization 2003.

144. Hu G, Lindström J, Tuomilehto J. Prevention of type 2 diabetes by exercise intervention. In: Cranston I, Hopkins D, Wilding J, Williams G ed. Diabetes. The Royal Society of Medicine, 2003: 20: 91-96.

145. Qu XS, "Lifestyle, Behaviour and Health" (two chapters by Hu G). Tianjin Science and Technology Press. 1994 (in Chinese).

Other Articles Not Peer Reviewed

146. Hu G, Tuomilehto J. Joint effect of physical activity and obesity on the risk of heart failure. e-journal of Cardiology Practice 2010; 8: 29. 

147. Hu G, Tuomilehto J. Physical activity cuts stroke risk. e-journal of Cardiology Practice 2006; 4: 25.

148. Hu G, Tuomilehto J. Hypertension combined with type 2 diabetes increases the risk of stroke. e-journal of Cardiology Practice 2006; 4: 27.

149. Hu G, Jousilahti, Tuomilehto J. Exercise can reduce cardiovascular disease in people with type 2 diabetes. e-journal of Cardiology Practice 2005; 3: 31.

150. Hu G, Tuomilehto J. The impact of diabetes and myocardial infarction on mortality from coronary heart disease. e-journal of Cardiology Practice 2004; 2: 31.

151. Hu G, Tuomilehto J. Asymptomatic diabetes and cardiovascular risk. e-journal of Cardiology Practice 2003; 1: 6.

Submitted Manuscripts

152. Shi Z, Hu XS, Yuan BJ, Hu G, Pan XQ, Dai Y, Holmboe-Ottesen G, Byles JE. Association between different kinds of physical activity and hyperglycemia among Chinese adults (Submitted for Publication).

153. Shi Z, Taylor AW, Hu G, Gill T, Wittert G. Rice intake, weight change and risk of metabolic syndrome development among Chinese adults: the Jiangsu Nutrition Study (JIN) (Submitted for Publication).

154. Shi Z, Wittert GA Yuan B, Dai Y, Gill TK, Hu G, Adams R, Zuo H, Taylor AW. Association between monosodium glutamate intake and snoring and obstructive sleep apnoea among Chinese adults with and without overweight (Submitted for Publication).

155. Shi ZM, Yuan BJ, He GL, Xu ZZ, Hu G. No change in prevalence of overweight and obesity among adolescents from 2002 to 2007 in Jiangsu Province China. Public Health Nutrition (Submitted for Publication).

156. Zuo H, Shi S, Yuan B, Dai Y, Hu G, Wu G, Hussain A. Interaction between sleep duration and physical activity in relation to insulin resistance among non-diabetic Chinese adults (Submitted for Publication).

157. Wang Y, Tuomilehto J, Jousilahti P, Antikainen R, Mähönen M, Katzmarzyk PT, Hu G. Lifestyle Factors in Relation to Heart Failure among Finnish Men and Women.

158. Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G. Lifestyle Factors on the Risk of Total and Type-Specific Stroke: A Cohort Study

In Development

159. Chen, L, Wang Y, Xiao K, Horswell R, Johnson J, Zhang CL, Hu G. Risk of hypertension after the gestational diabetes: findings from a large multi-ethnicity cohort study in Louisiana.

160. Chen, L, Zhang Y, Horswell R, Johnson J, Hu G. Evaluation of the Finnish diabetes risk score among U.S. adults.

161. Shi ZM, Yuan BJ, Hu G, Dai Y, Zuo H, Holmboe-Ottesen G. Dietary pattern and serum lipids change in a 5 year follow up among Chinese adults: Results from Jiangsu Nutrition and Health Study.

162. Wang Y, Chen L, Xiao K, Horswell R, Besse J, Johnson J, Ryan DH, Hu G. Increasing prevalence of gestational diabetes mellitus in Louisiana, 1997-2009.

163. Wang Y, Chen L, Horswell R, Xiao K, Besse J, Johnson J, Ryan DH, Hu G. A History of Gestational Diabetes Mellitus Predicts Type 2 Diabetes among Louisiana women.

164. Wang Y, Li W, Chen L, Horswell R, Xiao K, Besse J, Johnson J, Ryan DH, Hu G. Increasing prevalence of diabetes in Louisiana from 1998 to 2009.

165. Zhang Y, Tuomilehto J, Jousilahti P, Antikainen R, Hu G. Serum total and high-density lipoprotein cholesterol and the risk of total and type-specific stroke.

Abstracts at Professional Meetings:

Oral Presentation:

1. Hu G, Wang Y, Jousilahti P, Antikainen R, Mähönen M, Katzmarzyk PT, Tuomilehto J. Lifestyle factors in relation to heart failure. Joint Conference – 51st Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Atlanta, Georgia, March 22-25, 2011.

2. Zhang Y, Tuomilehto J, Jousilahti P, Hu G. Lifestyle Factors and the Risk of Stroke. Joint Conference – 51st Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Atlanta, Georgia, March 22-25, 2011.

3. Hu G, Wang Y, Jousilahti P, Antikainen R, Katzmarzyk PT, Tuomilehto J. Occupational, commuting, and leisure time physical activity and risk of heart failure. Joint Conference – 50th Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, San Francisco, CA. March 2-5, 2010.

4. Hu G, Jousilahti P, Antikainen R, Tuomilehto J. Joint effects of physical activity and body mass index with the risk of heart failure. Joint Conference – 49th Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Palm Harbor, Florida. March 10-14, 2009.

5. Hu G, Jousilahti P, Salomaa V, Tuomilehto J. Serum C-reactive protein and the risk of type 2 diabetes – a prospective study in Finland. European Diabetes Epidemiology Group 43rd Annual Meeting, Elsinore, Denmark. April 5-8, 2008.

6. Shi ZM, Hu XS, Yuan BJ, Hu G, Pan XQ, Dai Y, Holmboe-Ottesen G, Byles JE. Association between vegetable rich healthy food pattern and metabolic syndrome in China. 1st Diabetes in Asia Study Group Conference, Kathmandu, Nepal. October 16-18, 2008.

7. Tuomilehto J, Hu G, Jousilahti P. Adiposity and the risk of stroke. European Society of Cardiology Congress 2007, Vienna, Austria. September 1-5, 2007.

8. Bidel S, Hu G, Qiao Q, Jousilahti P, Antikainen R, Tuomilehto J. Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. European Society of Cardiology Working group on Epidemiology and Prevention Meeting (EuroPRevent 2006). Athens, Greece. May 11-13, 2006.

9. Hu G, Jousilahti P, Antikainen R, Bidel S, Tuomilehto J. The history of diabetes at baseline and the risk of Parkinson’s disease. European Diabetes Epidemiology Group 41st Annual Meeting, Krakow, Poland. May 20-23, 2006.

10. Hu G, Jousilahti P, Antikainen R, Bidel S, Tuomilehto J. The history of diabetes at baseline and the risk of Parkinson’s disease. American Diabetes Association (ADA) 66th Scientific Sessions, Washington, DC, USA. June 9-13, 2006.

11. Hu G, Sarti C, Jousilahti P, Peltonen M, Qiao Q, Tuomilehto J. Diabetes and hypertension together increase severely the risk of stroke. 14th European Stroke Conference, Bologna, Italy. 25-28 May, 2005.

12. Barengo NC, Hu G, Lakka TA, Pekkarinen H, Nissinen A, Tuomilehto J. Low physical activity as a predictor for total and cardiovascular disease mortality in middle-aged men and women in Finland. International XVIII Puijo Symposium "Physical Activity in Conjunction with Pharmacological Therapy for Chronic Vascular Diseases", Kuopio, Finland. June 29-July 2, 2005.

13. Hu G, Jousilahti P, Borodulin K, Barengo NC, Lakka TA, Nissinen A, Tuomilehto J. Occupational, commuting, and leisure-time physical activity in relation to coronary heart disease. International XVIII Puijo Symposium "Physical Activity in Conjunction with Pharmacological Therapy for Chronic Vascular Diseases", Kuopio, Finland. June 29-July 2, 2005.

14. Hu G, Jousilahti P, Tuomilehto J. Occupational, commuting, and leisure-time physical activity in relation to cardiovascular mortality among subjects with high blood pressure. International XVIII Puijo Symposium "Physical Activity in Conjunction with Pharmacological Therapy for Chronic Vascular Diseases", Kuopio, Finland. June 29-July 2, 2005.

15. Hu G, Jousilahti P, Tuomilehto J. The impact of diabetes and stroke at baseline and during follow-up on stroke mortality. European Association for the Study of Diabetes (EASD) 41st Annual Conference, Athens, Greece. September 10-15, 2005.

16. Jousilahti P, Hu G, Tuomilehto J. Risk of stroke among 50922 Finnish men and women at different levels of blood pressure with and without antihypertensive drug treatment. The 13th Nordic Meeting on Cerebrovascular Diseases, Göteborg, Sweden. September 22-24, 2005.

17. Franks PW, Hu G, Brage S, Luan J, Ekelund U, Tuomilehto J, Wareham NJ for the DECODE Study group. Syndrome-Z: a new approach to defining clustered metabolic risk. Prediction of early death in 13,000 European men and women from the collaborative DECODE Study. 13th European Congress on Obesity, Prague, Czech Republic. May 26-29, 2004.

18. Hammar N, Johansson S, Hu G, Peltonen M, Qiao Q, Tuomilehto J for the DECODE Study Group. Metabolic syndrome, smoking and cardiovascular mortality. European Society of Cardiology Working group on Epidemiology and Prevention Meeting, Helsingør, Denmark. June 9-12, 2004.

19. Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J. The impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from coronary heart disease. European Society of Cardiology Working group on Epidemiology and Prevention Meeting, Helsingør, Denmark. June 9-12, 2004.

20. Tuomilehto J, Hu G, Jousilahti P, Peltonen M, Lindström J. Urinary sodium, potassium excretion and the risk of type 2 diabetes: a prospective study in Finland. European Association for the Study of Diabetes (EASD) 40th Annual Conference, Munich, Germany. September 5-9, 2004.

21. Hu G, Qiao Q, Tuomilehto J for the DECODE Study Group. Effect of smoking on the risk of all-cause, CVD and cancer mortality by the glucose tolerance status. 12th World Conference on Tobacco or Health, Helsinki, Finland. August 3-8, 2003.

22. Balkau B, Hu G, Tuomilehto J, Borch-Johnsen K for the DECODE Study Group. A risk score for all cause and cardiovascular mortality: including glucose as an additional factor. The DECODE Study. International Diabetes Epidemiology Group 9th Meeting and European Diabetes Epidemiology Group 38th Annual Meeting, Tours, France. August 20-23, 2003.

23. Hu G, Lindström J, Valle T, Eriksson J, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J. Physical activity, body mass index in relation to risk for type 2 diabetes in subjects with normal glucose and impaired glucose regulation. International Diabetes Epidemiology Group 9th Meeting and European Diabetes Epidemiology Group 38th Annual Meeting, Tours, France. August 20-23, 2003.

24. Hu G, Tuomilehto J, Qiao Q, Eliasson M, Feskens E, Pyörälä K for the DECODE Study Group. Hyperinsulinemia as a risk factor for cardiovascular mortality in non-diabetic European men and women. International Diabetes Epidemiology Group 9th Meeting and European Diabetes Epidemiology Group 38th Annual Meeting, Tours, France. August 20-23, 2003.

25. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K for the DECODA Study Group. Hyperglycemia and mortality in Japanese and Indian populations-results of the DECODA follow-up data. International Diabetes Epidemiology Group 9th Meeting and European Diabetes Epidemiology Group 38th Annual Meeting, Tours, France. August 20-23, 2003.

26. Qiao Q, Hu G, Pyörälä K, Tuomilehto J for the DECODE Study Group. The prevalence of the metabolic syndrome in Europe using four proposed definitions. International Diabetes Epidemiology Group 9th Meeting and European Diabetes Epidemiology Group 38th Annual Meeting, Tours, France. August 20-23, 2003.

27. Tuomilehto J, Hu G, Lindström J, Jousilahti P. Coffee consumption and risk of type 2 diabetes among middle-aged Finnish men and women. International Diabetes Epidemiology Group 9th Meeting and European Diabetes Epidemiology Group 38th Annual Meeting, Tours, France. August 20-23, 2003.

28. Hu G, Tuomilehto J, Jousilahti P. Physical activity, body mass index, waist to hip ratio, and the risk for all-cause and cardiovascular mortality among middle-aged Finnish men and women. European Society of Cardiology Congress 2003, Vienna, Austria. August 30-September 3, 2003.

29. Tuomilehto J, Hu G, Qiao Q, Mats Eliasson, Edith Feskens, Pyörälä K for the DECODE Study Group. Hyperinsulinemia as a risk factor for cardiovascular mortality in non-diabetic European men and women. European Society of Cardiology Congress 2003, Vienna, Austria. August 30-September 3, 2003.

30. Qiao Q, Hu G, Tuomilehto J, Balkau B, Borch-Johnsen K for the DECODA Study Group. Age and sex specific prevalence of diabetes and impaired glucose regulation in 10 Asian cohorts. 5th International Diabetes Federation Western Pacific Region Congress, Beijing, China. May 4-7, 2002.

31. Sarti C, Hu G, Qiao Q, Tuomilehto J for the DECODE Study Group. Mortality from stroke and the metabolic syndrome in Europe. 11th International Stroke Conference, Geneva, Switzerland. May 29-June 1, 2002.

32. Hu G, Qiao Q, Silventoinen K, Eriksson J, Jousilahti P, Lindström J, Valle T, Nissinen A, Tuomilehto J. Occupational, commuting, leisure time physical activity in relation to risk for type 2 diabetes in middle-aged Finnish men and women. European Association for the Study of Diabetes (EASD) 38th Annual Conference, Budapest, Hungary. September 1-5, 2002.

33. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K for the DECODE Study Group. The prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality. 3rd World Congress on Prevention and Diabetes and its Complications, Hong Kong. September 29-October 1, 2002.

34. Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens E, Pyörälä K for the DECODE Study Group. Hyperinsulinemia as an independent risk factor for cardiovascular mortality in both men and women. 3rd World Congress on Prevention and Diabetes and its Complications, Hong Kong. September 29-October 1, 2002.

35. Hu G, Pekkarinen H, Kumpusalo E, Halonen P, Hänninen O, Tian HG, Guo ZY. Health profiles comparison between Finnish and Chinese Populations. Finnish General Practice Conference, Helsinki, Finland. 1999.

36. Hu G, Tian HG, Nan Y. Assessment intake of food and nutrient in different income Chinese urban people. National Conference on Public Nutrition, China. June, 1996 (in Chinese).

37. Yu ZJ, Nan Y, Yang XL, Hu G, Tian HG. Establishment of salt intake surveillance system for evaluation of a community-based hypertension control program. National Conference on Public Nutrition, China. June, 1996 (in Chinese).

38. Nan Y, Yang X, Jia M, Dong Q, Hu G. An analysis of serum lipid levels and their associated factors in Tianjin residents. Seventh National Conference of Nutrition of China, Chengdu, China. September 1996 (in Chinese).

39. Hu G, Nan Y, Dong Q, Yang X, Tian H. Analysis of nutritional status of Tianjin residents with different incomes. National Conference on Chronic Diseases Control and Prevention, Tianjin, China. October, 1996 (in Chinese).

40. Yang X, Jia M, Wu J, Hu G. Study on association between nutrition environment and nutrient intake and nutrition intervention. National Conference on Chronic Diseases Control and Prevention, Tianjin, China. October, 1996 (in Chinese).

41. Yu ZJ, Nan Y, Hu G, Tian HG. Effects of nutrition intervention on salt consumption in Tianjin. National Conference on Chronic Diseases Control and Prevention, Tianjin, China. October, 1996 (in Chinese).

42. Yu ZJ, Nan Y, Hu G, Tian HG. Trends in salt consumption in Tianjin: 1992-1994. First National Conference on Chronic Disease Control and Prevention, Tianjin, China. October, 1994 (in Chinese).

43. Tian HG, Nan Y, Yu ZJ, Hu G. The approach of enhanced food and health food evaluation. Chinese Food Safety Control Conference, China. October, 1991 (in Chinese).

Poster Presentation:

1. Hu G, Bouchard C, Bray GA, Greenway FL, Johnson WD, Newton Jr RL, Ravussin E, Ryan DH, Katzmarzyk PT. Trunk versus extremity adiposity and cardiometabolic risk factors in white and African American adults. Joint Conference – 51st Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Atlanta, Georgia, March 22-25, 2011.

2. Chen L, Wang Y, Xiao K, Horswell R, Hu G. Race and body size influence the risk of hypertension after the gestational diabetes. Joint Conference – 51st Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Atlanta, Georgia, March 22-25, 2011.

3. Bowers K, Hu G, Yu Z, Yang X, Klebanoff M, Yeung E, Zhang C. Postnatal weight gain and high blood pressure among Chinese children. The 43rd Annual Society for Epidemiologic Research (SER) Meeting, Seattle, Washington. June 23-26, 2010.

4. Chen LW, Zhang Z, Caballero B, Appel LJ, Hu G. Habitual coffee consumption and risk of hypertension: a meta-analysis of prospective studies. Joint Conference – 50th Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, San Francisco, CA. March 2-5, 2010

5. Zhang FX, Dong L, Zhang CP, Li BJ, Wen J, Gao W, Sun SR, Lv FJ, Tian HG, Tuomilehto J, Qi L, Zhang CL, Yu ZJ, Yang XL, Hu G. Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. American Diabetes Association (ADA) 70th Annual Scientific Sessions, Orlando, Florida, June 25-29, 2010.

6. Xiao K, Chen L, Hu G. Increasing prevalence of gestational diabetes mellitus in Louisiana, 1997-2009. The 43rd Annual Society for Epidemiologic Research (SER) Meeting, Seattle, Washington. June 23-26, 2010.

7. Hu G, Tuomilehto J. Blood pressure and the risk of type 2 diabetes. American Diabetes Association (ADA) 69th Annual Scientific Sessions, New Orleans, Louisiana. June 6-9, 2009.

8. Hu G, Tuomilehto J, Antikainen R, Jousilahti P. Does serum gamma-glutamyltransferase level predict the risk of heart failure? Joint Conference – 49th Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Palm Harbor, Florida. March 10-14, 2009.

9. Hu G, Jousilahti P, Tuomilehto J. Associations of total and high-density lipoprotein cholesterol with the risk of coronary heart disease and total and type-specific stroke. Joint Conference – 48th Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Colorado Springs, Colorado, USA. March 11-15, 2008.

10. Hu G, Jousilahti P, Tuomilehto J. Serum triglycerides and the risk of incident coronary heart disease and stroke. European Society of Cardiology Congress 2008, Munich, Germany. August 30-September 3, 2008

11. Hu G, Lehtisalo R, Tuomilehto J. Blood pressure and the risk of type 2 diabetes. 5th World Congress on Prevention of Diabetes and its Complications (WCPD 2008), Helsinki, Finland. June 1-4, 2008.

12. Jousilahti P, Tuomilehto, Hu G, Sundvall J, Salomaa V. Sensitive C-reactive protein and the risk of type 2 diabetes mellitus – a prospective study in Finland. Joint Conference – 48th Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Colorado Springs, Colorado, USA. March 11-15, 2008.

13. Hu G, Tuomilehto J, Silventoinen K, Sarti C, Jousilahti P. Body mass index, waist circumference and waist-to-hip ratio on the risk of total and type-specific stroke. Joint Conference – 47th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in association with the Council on Nutrition, Physical Activity, and Metabolism, Orlando, Florida, USA. February 28-March 3, 2007. 

14. Hu G, Jousilahti P, Tuomilehto J. Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease. European Diabetes Epidemiology Group 42nd Annual Meeting, Cambridge, UK. March 31-April 3, 2007.

15. Hu G, Tuomilehto J, Borodulin K, Jousilahti P. The joint effect of physical activity and Framingham risk score on coronary heart disease risk. Joint Conference – 46th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in association with Council on Nutrition, Physical Activity, and Metabolism, Phoenix, Arizona, USA. March 2-5, 2006.

16. Hu G, Jousilahti P, Tuomilehto J. 10-year trends in prevalence of the metabolic syndrome among Finnish adults. European Association for the Study of Diabetes (EASD) 42nd Annual Conference, Copenhagen-Malmoe, Denmark-Sweden. September 14-17, 2006.

17. Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J. The impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. European Diabetes Epidemiology Group 40th Annual Meeting, Siofok, Hungary. April 2-5, 2005.

18. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K for the DECODA Study Group. Screen detected diabetes, hypertension and hypercholesteremia as predictors of fatal cardiovascular disease in five populations of Asian origin. European Diabetes Epidemiology Group 40th Annual Meeting, Siofok, Hungary. April 2-5, 2005.

19. Hu G, Eliasson M, Peltonen M, Stegmayr B, Qiao Q, Tuomilehto J. The metabolic syndrome and the risk of cardiovascular disease: assessment of four suggested definitions of the metabolic syndrome. 1st International Congress on `Prediabetes` and the Metabolic Syndrome - Epidemiology, Management and Prevention of Diabetes and Cardiovascular Disease, Berlin, Germany. April 13-16, 2005.

20. Hu G, Jousilahti P, Peltonen M, Qiao Q, Tuomilehto J. The Metabolic Syndrome and Incident Diabetes: Assessment of Four Suggested Definitions of the Metabolic Syndrome. American Diabetes Association (ADA) 65th Annual Scientific Sessions, San Diego, California, USA. June 10-14, 2005.

21. Jousilahti P, Hu G, Peltonen M, Qiao Q, Tuomilehto J. The impact of history of hypertension and diabetes at baseline on the risk of stroke incidence and stroke mortality. American Diabetes Association (ADA) 65th Annual Scientific Sessions, San Diego, California, USA. June 10-14, 2005.

22. Jousilahti P, Hu G, Borodulin K, Tuomilehto J. Occupational, commuting and leisure time physical activity and cardiovascular disease mortality among hypertensive subjects - A prospective follow-up of 26723 Finnish men and women. American Heart Association 2005 Annual Scientific Sessions, Dallas, Texas, USA. November 13-16, 2005.

23. Hu G, Eriksson J, Barengo NC, Lakka TA, Valle T, Nissinen A, Jousilahti P, Tuomilehto J. Occupational, commuting, and leisure time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes. European Diabetes Epidemiology Group 39th Annual Meeting, Vietri Sul Mare, Italy. April 24-27, 2004.

24. Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J. Physical activity protects against cardiovascular mortality among middle-aged men and women with type 2 diabetes. European Association for the Study of Diabetes (EASD) 40th Annual Conference, Munich, Germany. September 5-9, 2004.

25. Nakagami T, Qiao Q, Tuomilehto J, Hu G, Balkau B, Tajima N, Borch-Johnsen K for the DECODA Study Group. Prevalence of the metabolic syndrome and its impact on all-cause and cardiovascular mortality in three Asian origin populations. European Association for the Study of Diabetes (EASD) 40th Annual Conference, Munich, Germany. September 5-9, 2004.

26. Qiao Q, Hu G, Peltonen M, Tuomilehto J for the DECODE Study Group. Risk of death from all-cause and cardiovascular disease (CVD) related to the different definitions of the metabolic syndrome (MS) and to individual metabolic abnormalities. European Association for the Study of Diabetes (EASD) 40th Annual Conference, Munich, Germany. September 5-9, 2004.

27. Wang JJ, Hu G, Miettinen M, Tuomilehto J. The metabolic syndrome and incident diabetes: Assessment of four suggested definitions of the metabolic syndrome in a Chinese population with high post-prandial glucose. European Association for the Study of Diabetes (EASD) 40th Annual Conference, Munich, Germany. September 5-9, 2004.

28. Jousilahti P, Hu G, Tuomilehto. Single and joint effects of obesity and physical activity on stroke risk. American Heart Association 2004 Annual Scientific Sessions, New Orleans, USA. November 6-10, 2004.

29. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Johansson S, Kennerfalk A, Pyörälä K for the DECODE Study Group. The metabolic syndrome and total and cardiovascular mortality in non-diabetic European men and women. 18th International Diabetes Federation (IDF) Congress, Paris, France. August 24-29, 2003.

30. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K for the DECODE Study Group. Gender difference in cardiovascular and all-cause mortality related to hyperglycaemia and newly diagnosed diabetes. European Diabetes Epidemiology Group 37th Annual Meeting, St Catherine’s College, Oxford, UK. March 23-26, 2002.

31. Qiao Q, Hu G, Tuomilehto J, Balkau B, Borch-Johnsen K for the DECODE Study Group. Age and sex specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts. European Diabetes Epidemiology Group 37th Annual Meeting, St Catherine’s College, Oxford, UK. March 23-26, 2002.

32. Nakagami T, Qiao Q, Carstensen B, Nøhr-Hansen C, Hu G, Tuomilehto J, Balkau B, Borch-Johnsen K for the DECODA Study Group. Age, BMI and Type 2 Diabetes – association modified by ethnicity. European Association for the Study of Diabetes (EASD) 38th Annual Conference, Budapest, Hungary. September 1-5, 2002.

33. Hu G, Pekkarinen H, Hanninen O, Guo ZY, Tian HG. A comparison of dietary and non-dietary factors in overweight and normal weight Chinese people. 15-Year Anniversary Symposium of the Department of Clinical Nutrition, Kuopio, Finland. March 25-26, 1999.

34. Yang X, Hsu-Hage B. H-H, Tian HG, Hu G, Dong Q, Wu Z, Wahlqvist ML. The role of income and education in food consumption and nutrient intake in a Chinese population. Twenty-first Annual Scientific Meeting of the Nutrition Society of Australia, Brisbane, Australia. November 30-December 2, 1997.

ADDITIONAL INFORMATION

Main research interests:

• Different kinds of physical activity (occupational, commuting, and leisure time), obesity and their combined effects on the risk of several chronic diseases, including type 2 diabetes, hypertension, coronary heart disease, heart failure, stroke, and cancer;

• Insulin resistance, glucose tolerance, the metabolic syndrome and the risks of type 2 diabetes, cardiovascular disease and cancer;

• The independent and joint effects of diabetes, myocardial infraction, stroke, hypertension and other cardiovascular risk factors on the risk of cardiovascular mortality;

• Coffee and alcohol consumption and the risk of several chronic diseases, including type 2 diabetes, hypertension, coronary heart disease, heart failure, stroke, and cancer;

• Dietary factors and the risk of several chronic diseases, including obesity, hypertension, type 2 diabetes, coronary heart disease, heart failure, Parkinson’s disease and different types of cancer;

• The interaction in lifestyle and genetic factors on the risk of type 2 diabetes in women with gestational diabetes.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download